You are here

Jul 22, 2014

Professor Ernest Giralt, co-founder of Iproteos and SAB president, has been awarded with The Josef Rudinger Memorial Lecture Award. This recognized award honours a candidate with outstanding contributions to peptide chemistry. Prof. Giralt extense career has been devoted, among many other scientific challenges, to the development of peptide synthesis methodologies, peptide structure study and the use of peptides as shuttles.

Jul 04, 2014

Iproteos has been invited to give a speech at the Entrepreneurial Technology Fair 2014 that will be held on 9th of July. The goal of the event is to establish contacts and foster collaboration projects with students and old members of IESE. In total, six projects with clear focus to the commercialization of innovative technologies have been selected.

Jun 18, 2014

Iproteos has just released an innovative campaign based on Equity crowdfunding. It is the first time that this strategy is used in a Spanish biotechnological project. The company aims to generate a pioneering manner of raising funds for early stage biotech companies, as it is carried out in United Kingdom and France. The objective of the campaign is to raise 100,000€ to complete the non-regulatory preclinical trials of a project devoted to a treatment for Schizophrenia. This will allow Iproteos to attract further investment to move on to clinical trials in patients.

Jun 16, 2014
May 13, 2014

BizBarcelona, an international forum for SMEs and entrepreneurs, has invited Iproteos CEO, Teresa Tarrago, to participate in a forum discussion named "El moment de la creació: de la recerca pública a l'empresa tecnològica" (The moment of creation: from public research to technological company), that will be held on 5th June at 5 p.m.

Additional information can be found in:

May 02, 2014

Iproteos is attending the 2014 BIO International Convention that will be held on 23th-26th of June at the San Diego Convention Center (San Diego, California). Further information about the convention can be found here.